drugset / Trial / NCT01702103

Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays

NCT01702103

Phase 3 Unknown 360 enrolled PH&T S.p.A.
RandomizedParallel-groupQuadruple-blind

Summary

Demonstrate the therapeutic clinical equivalence of two mometasone nasal sprays in the relief of the signs and symptoms of perennial allergic rhinitis, in term of changes at week 8 from baseline of Total Nasal Symptom Scores (TNSS).

Timeline

Start
2012-10
Primary completion
2013-01
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified Other